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Available online 21 January 2013AbstractHypereosinophilic syndrome is a rare disorder with an incidence rate of 0.36 to 6.3 per 100,000 persons. It is characterized by a sustained
overproduction of eosinophils, peripheral eosinophilia, and organ damage by eosinophils. Cardiac involvement is the major cause of death in
patients with hypereosinophilic syndrome. Clinical presentations of cardiac involvement include heart failure, intracardiac thrombus, myocardial
ischemia, arrhythmia, and pericarditis. Most of these patients present with chest tightness and dyspnea. Arrhythmia is seldom mentioned in these
cases. We report an 80-year-old man who presented to the emergency department with junctional bradycardia.
Copyright  2012, Taiwan Society of Emergency Medicine. Published by Elsevier Taiwan LLC. All rights reserved.
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Hypereosinophilic syndrome (HES) is a rare disorder
characterized by a sustained overproduction of eosinophils,
peripheral eosinophilia, and eosinophilic tissue infiltration.1
HES has various clinical presentations, ranging from fatigue
and other nonspecific complaints to fatal cardiac and neuro-
logical involvement. Cardiac involvement is the major cause
of morbidity and mortality in HES.2 The most common
symptom of cardiac involvement in HES patients is heart
failure, followed by chest pain and systemic thromboembolic
events. We report a patient who presented with junctional
rhythm in the emergency department (ED) and was subse-
quently diagnosed with HES.* Corresponding author. Department of Emergency Medicine, Chang Gung
Memorial Hospital-Kaohsiung, Number 123, Ta-Pei Road, Niao-Sung,
Kaohsiung 833, Taiwan.
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An 80-year-old man presented to the ED with sudden-onset
chest tightness and dyspnea for 5e6 hours. He had a history of
hypertension, diabetes mellitus with nephropathy (2 years),
chronic kidney disease (stage IV), and duodenal ulcer with
irregular medication control. He denied coughing, cold sweats,
fever, tarry stools, abdominal pain, and radiating pain. His
blood pressure was 116/71 mmHg, his heart rate was 42 beats/
min (BPM), and his respiratory rate was 20/min. There were
no other remarkable findings during physical examination
except for the low heart rate. Electrocardiography (EKG)
showed junctional bradycardia, without significant ST-T
changes (Fig. 1). The initial laboratory examination revealed
a white blood cell count of 33.38  103/mL, with 32%
eosinophils (absolute eosinophil count 10.681  103/mL),
creatinine 5.4 mg/dL, creatine kinase-MB 1.2 ng/ml, troponin
I 0.037 ng/ml, and glucose 238 mg/dL. Results for the
hematocrit, coagulation function, electrolyte levels, thyroid
function, adrenal function, and other routine biochemicalMedicine. Published by Elsevier Taiwan LLC. All rights reserved.
Fig. 1. Initial EKG reveals junctional bradycardia.
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revealed an enlarged heart with Kerley B lines. Based on the
symptomatic junctional bradycardia, atropine and dopamine
were administered in the ED with no obvious response. The
patient was then admitted to the coronary care unit for
monitoring and diagnostic evaluation. Dopamine was admin-
istered at 10 mg/kg/min. His heart rate was approximately
40e45 BPM. The results of transthoracic Doppler echocar-
diography showed four chambers with no abnormalities and
four functioning valves. Cardiac enzyme analysis showed
creatine kinase-MB 13.1 ng/ml and troponin I 6.097 ng/ml. A
Tl-201 myocardial perfusion scan showed no abnormalities.
On the basis of these results, HES was suspected. Prednisolone
(0.5 mg/kg per day) was prescribed, and additional diagnostic
examinations were performed. Examination of blood and stool
showed no evidence of an allergic reaction or parasite infec-
tion. The results from serological analysis of autoantibodies to
nuclear antigen, complement 3, complement 4, antiextractableFig. 2. Subsequent EKG showed normal sinus rhnuclear antigen, rheumatoid factor, and immunoglobulins G,
A, E, and M were within reference limits. Bone marrow biopsy
results revealed no evidence of hematological malignancy. An
EKG showed normal sinus rhythm 2 days after admission, and
the heart rate was approximately 70 BPM (Fig. 2). Dopamine
was discontinued. He was discharged on day 13. One year
later, his white blood cell count was 20,000 to 25,000 cells/mL,
with 5% to 10% eosinophils, and he had no episodes of
bradycardia.
3. Discussion
HES is a rare disease with an estimated prevalence of
0.36e6.3 per 100,000 persons.3 HES is defined as blood
eosinophilia greater than 1500 cells/mL for longer than 6
months with symptoms of organ involvement in the absence of
identifiable causes of hypereosinophilia such as parasite
infections and allergic reactions.1,4,5 Our patient presentedythm with heart rate of about 70 beats/min.
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included junctional bradycardia, elevated troponin I, and
marked hypereosinophilia. Certain clinical disorders may
result in hypereosinophilia with myocardial injury, including
HES with cardiac involvement, eosinophilic leukemia with
cardiac injury, vasculitis and granulomatous diseases, drug
reactions, transplant rejection, and acute coronary syndrome
with coexisting HES. Eosinophilic leukemia was ruled out by
bone marrow biopsy in our patient. Autoimmune disease, such
as ChurgeStrauss syndrome, was unlikely because of the
absence of asthma, paranasal sinusitis, histological proof of
vasculitis, evidence of neuritis, and negative results for sero-
logic markers of autoimmune disease. Drug reactions and
transplant rejection were rejected based on the patient’s
medical history. Acute coronary syndrome was also ruled out
based on a negative Tl-201 myocardial perfusion scan.
Therefore, the diagnosis was HES with cardiac involvement.
A junctional rhythm initiates within the atrioventricular
nodal tissue. In autonomic tone changes or sinus node disease,
inappropriate slowing of the sinus node can occur, inducing
junctional rhythm. The possible causes of junctional rhythm
include sick sinus syndrome, myocardial injury such as
cardiac surgery, inflammatory processes involving the con-
ducting system, sinoatrial node ischemia, effects of drugs such
as digitalis, and electrolyte imbalance such as hyperkalemia
and hypercalcemia.6 In our patient, drug effects and electrolyte
imbalance were ruled on the basis of the patient’s history and
initial blood tests. His EKG showed normal sinus rhythm after
steroid treatment, and there were no episodes of bradycardia
after a 1-year follow-up. Thus, sick sinus syndrome was not
favored. Sinoatrial node ischemia was also ruled out based on
a negative Tl-201 myocardial perfusion scan. So, myocardial
injury involving the conducting system was the most likely
cause of the junctional rhythm in this case.
The symptoms and signs of HES depend on the degree of
end-organ eosinophilic damage. One retrospective study of
188 patients reported that dermatologic presentation was the
most frequently reported initial symptom in these patients.
However, only 5% of patients presented with cardiac
involvement.7 Nonetheless, cardiac involvement has been
shown to be the major cause of morbidity and mortality
associated with HES.1,2,8,9 Clinical presentations of cardiac
involvement include heart failure, intracardiac thrombosis,
myocardial ischemia, arrhythmia, and pericarditis.10 Chest
pain and dyspnea are the most common symptoms in these
patients.11 EKG results show ST elevation, ST depression,
atrial flutter, bundle branch block, and other nonspecific
findings.11,12 Consequently, patients may be misdiagnosed
with acute myocardial infarction.13 In a retrospective study,
Kawano et al11 reported seven cases over a 27-year period.
EKG abnormalities were corrected in two of the seven patients
following treatment. Our patient presented with chest tightness
and dyspnea, with initial EKG results indicating junctional
bradycardia. His EKG showed a corrected sinus rhythm after
corticosteroid use.Specific therapy is not needed in patients with eosinophilia
without evidence of end-organ damage. However, HES
patients with vital organ involvement require treatment.1
Corticosteroids remain the first line of treatment for most
patients.9 High-dose prednisolone (1 mg/kg per day) as the
initial regimen is recommended in some studies.1,14 If patients
are refractory to corticosteroids or cannot tolerate them,
alternative therapies can be considered. These alternatives
include cytotoxic agents, such as hydroxyurea, and immuno-
modulatory agents, such as alemtuzumab and cyclosporine.
In conclusion, cardiac involvement is the major cause of
death in patients diagnosed with HES. HES must be consid-
ered in patients with hypereosinophilia in the absence of
identifiable causes. Therefore, HES with cardiac involvement
should be included in the differential diagnosis of patients
reporting chest tightness and dyspnea with associated hyper-
eosinophilia. Corticosteroids should be initiated in these cases.References
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